HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radioimmunoprecipitation and immunoblot studies of antibodies to rubella virus in patients with chronic liver disease.

Abstract
Patients with autoimmune chronic active hepatitis (AICAH) and some other chronic liver disorders often have very high titres of rubella HI antibodies. In the present study sera from 46 patients with chronic liver disease and controls were examined for rubella antibodies using radioimmunoprecipitation assay (RIPA) and Western blot. RIPA appeared to be more suitable than Western blot for the study of the individual antibody specificities provided that proteins (possibly actin) interfering with the resolution of the E2 glycoprotein band are identified. It was shown that patients with high rubella HI titres reacted strongly against the E1 glycoprotein and in general also against the core protein (C). Reactivity to the E2 glycoprotein was detected with all sera from patients with chronic liver disease but varied more in strength. Three patients with post-acute rubella showed very faint E2 reactivity, but strong E1 and C reactivities. Patients with primary biliary cirrhosis had normal HI titres and showed no increase in reactivity in RIPA. The present findings show that patients with chronic liver disease and high rubella HI antibody titres exhibit an enhanced specific antibody response to rubella virus structural proteins.
AuthorsM B Kalvenes, K H Kalland, G Haukenes
JournalArchives of virology (Arch Virol) Vol. 136 Issue 1-2 Pg. 73-85 ( 1994) ISSN: 0304-8608 [Print] Austria
PMID8002792 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
Topics
  • Animals
  • Antibodies, Viral (analysis)
  • Blotting, Western
  • Chronic Disease
  • Electrophoresis, Gel, Two-Dimensional
  • Hepatitis, Chronic (immunology)
  • Humans
  • Immunoblotting
  • Liver Diseases (immunology, microbiology)
  • Radioimmunoprecipitation Assay
  • Rubella virus (immunology)
  • Vero Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: